Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001062443 | SCV001227244 | uncertain significance | not provided | 2023-06-05 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 856882). This variant has not been reported in the literature in individuals affected with IMPDH1-related conditions. This variant is present in population databases (rs372943232, gnomAD 0.005%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This sequence change falls in intron 7 of the IMPDH1 gene. It does not directly change the encoded amino acid sequence of the IMPDH1 protein. It affects a nucleotide within the consensus splice site. |
Prevention |
RCV004735953 | SCV005360464 | uncertain significance | IMPDH1-related disorder | 2024-08-15 | no assertion criteria provided | clinical testing | The IMPDH1 c.579+3A>G variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |